Free Trial

Graybug Vision (GRAY) Competitors

Graybug Vision logo
$3.08 -0.09 (-2.84%)
As of 09/5/2025

GRAY vs. ETHZ, IBIO, NBY, AEZS, MTNB, AEON, NRBO, CPHI, OGEN, and SPRB

Should you be buying Graybug Vision stock or one of its competitors? The main competitors of Graybug Vision include Flag Ship Acquisition (ETHZ), iBio (IBIO), NovaBay Pharmaceuticals (NBY), Aeterna Zentaris (AEZS), Matinas Biopharma (MTNB), AEON Biopharma (AEON), NeuroBo Pharmaceuticals (NRBO), China Pharma (CPHI), Oragenics (OGEN), and Spruce Biosciences (SPRB).

Graybug Vision vs. Its Competitors

Graybug Vision (NASDAQ:GRAY) and Flag Ship Acquisition (NASDAQ:ETHZ) are both small-cap pharmaceutical preparations industry companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Flag Ship Acquisition is trading at a lower price-to-earnings ratio than Graybug Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Graybug VisionN/AN/A-$35.60M-$24.23-0.13
Flag Ship AcquisitionN/AN/A-$6.17M-$15.07-0.15

In the previous week, Flag Ship Acquisition had 2 more articles in the media than Graybug Vision. MarketBeat recorded 2 mentions for Flag Ship Acquisition and 0 mentions for Graybug Vision. Flag Ship Acquisition's average media sentiment score of 0.54 beat Graybug Vision's score of 0.00 indicating that Flag Ship Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
Graybug Vision Neutral
Flag Ship Acquisition Positive

49.9% of Graybug Vision shares are owned by institutional investors. Comparatively, 4.1% of Flag Ship Acquisition shares are owned by institutional investors. 7.9% of Graybug Vision shares are owned by company insiders. Comparatively, 38.2% of Flag Ship Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Graybug Vision has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Flag Ship Acquisition has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500.

Graybug Vision's return on equity of -77.61% beat Flag Ship Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Graybug VisionN/A -77.61% -71.34%
Flag Ship Acquisition N/A -141.25%-80.77%

Summary

Flag Ship Acquisition beats Graybug Vision on 5 of the 9 factors compared between the two stocks.

Get Graybug Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRAY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRAY vs. The Competition

MetricGraybug VisionPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$8.64M$952.75M$5.83B$9.93B
Dividend YieldN/A4.84%6.70%4.52%
P/E Ratio-1.781.1276.1526.11
Price / SalesN/A26.54562.61123.62
Price / CashN/A19.5636.9959.28
Price / Book1.846.7311.486.09
Net Income-$35.60M-$3.82M$3.29B$266.51M
7 Day Performance14.07%0.54%1.27%0.46%
1 Month Performance2.67%12.25%7.94%4.59%
1 Year Performance-41.89%28.10%62.94%26.04%

Graybug Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRAY
Graybug Vision
N/A$3.08
-2.8%
N/A-37.5%$8.64MN/A-1.7827High Trading Volume
ETHZ
Flag Ship Acquisition
N/A$2.73
+2.2%
N/AN/A$16.49MN/A-0.187Gap Up
IBIO
iBio
1.947 of 5 stars
$0.83
+2.6%
$5.00
+501.0%
-54.6%$16.37M$375K0.00100News Coverage
NBY
NovaBay Pharmaceuticals
0.45 of 5 stars
$2.60
+13.9%
$0.85
-67.3%
+695.6%$15.13M$9.78M-0.0530Gap Down
AEZS
Aeterna Zentaris
N/A$3.08
+1.3%
N/A-20.4%$10.26M$2.37M-0.2120Gap Down
MTNB
Matinas Biopharma
0.2948 of 5 stars
$1.87
+2.2%
N/AN/A$9.67MN/A-0.3930Short Interest ↑
AEON
AEON Biopharma
3.2885 of 5 stars
$0.73
-1.6%
$360.00
+49,147.6%
-98.7%$8.50MN/A4.065News Coverage
Short Interest ↓
NRBO
NeuroBo Pharmaceuticals
N/A$0.63
-2.0%
N/A-79.6%$5.46MN/A0.0010
CPHI
China Pharma
0.1662 of 5 stars
$1.45
+2.1%
N/A-90.4%$4.73M$4.40M0.00250Negative News
Short Interest ↑
Gap Up
OGEN
Oragenics
0.6786 of 5 stars
$1.06
+0.5%
N/A-93.1%$4.35MN/A-0.155Positive News
Short Interest ↓
SPRB
Spruce Biosciences
1.6173 of 5 stars
$7.00
-6.7%
$131.25
+1,775.0%
-73.9%$3.93M$4.91M-7.4520News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:GRAY) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners